Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

..... "I share this with all of you because it exemplifies that dark side of the Internet and the lengths that some bad actors will go to. It also proves that with persistent effort and the right resources that those individuals can be identified, no matter how cleverly they believe they have covered their tracks.

We assured you that the lawsuit by the Rosen Law Firm was frivolous. The court agreed. We didn’t stop there. You can believe me that our team is on top of bringing the culprits behind the attack on Cellceutix to justice.

We encourage current and future CTIX shareholders to rely only upon credible sources, including our news releases, research data and filings with the Securities and Exchange Commission. To that point, I am pleased to say that as of this morning we are still on target to provide an efficacy report this week from the second cohort in the open label Phase 2 trial of Brilacidin for ulcerative colitis. We also are looking forward in the coming weeks to releasing an interim analysis of data from the double-blind Phase 2 study of Brilacidin-OM for the prevention and treatment of oral mucositis.

These are truly exciting times at Cellceutix and I thank you for the ongoing support."